Target intelligence / Profile preview

Glucose-6-phosphatase catalytic subunit mRNA 3'-untranslated region (G6PC mRNA 3'-UTR)

Target
G6PC mRNA 3'-UTR
Molecular classification
RNA, Untranslated region
01

Overview

The G6PC mRNA 3'-untranslated region (3'-UTR) is a non-coding regulatory segment of the messenger RNA that encodes the glucose-6-phosphatase catalytic subunit, the enzyme responsible for the final step of both gluconeogenesis and glycogenolysis in the liver and kidneys. This region serves as a scaffold for various regulatory elements, including AU-rich elements (AREs) and binding sites for microRNAs such as miR-494 and miR-122, which collectively dictate the stability and translational efficiency of the G6PC transcript. In metabolic disorders like Type 2 diabetes, G6PC is frequently overexpressed, contributing to excessive hepatic glucose output and hyperglycemia; consequently, the 3'-UTR is a primary target for antisense oligonucleotides (ASOs) and RNA interference (RNAi) therapies designed to trigger mRNA degradation and lower blood sugar. Conversely, genetic polymorphisms within this region, such as rs2229611, can impair mRNA stability and are associated with an increased risk or severity of Glycogen Storage Disease type Ia (GSD-Ia). Therapeutic strategies targeting this region aim to modulate glucose production by either silencing the endogenous transcript in overactive states or optimizing the stability of synthetic mRNA for replacement therapies in deficiency states.

Other names
G6Pase mRNA 3'-UTRG6PC1 mRNA 3'-UTRGlucose-6-phosphatase catalytic subunit 1 mRNA 3'-UTRG6PC 3'-untranslated region
02

Mechanism of action

Antisense inhibition, RNase H-mediated mRNA degradation, microRNA-mediated translational repression, and RNA interference (RNAi).

03

Biological functions

Regulation of mRNA stabilityRegulation of translationGlucose homeostasisGluconeogenesisGlycogenolysis
04

Disease associations

Type 2 diabetesGlycogen storage disease type IaMetabolic syndromeNonalcoholic steatohepatitis (NASH)Hepatocellular carcinoma
05

Safety considerations

HypoglycemiaHepatic steatosis (fatty liver)HepatomegalyHypertriglyceridemiaLactic acidosis
06

Interacting drugs

IONIS-G6PC-LRx (also known as IONIS-G6PCRx)

2 more in the full profile.

07

Biomarkers

Fasting blood glucoseHemoglobin A1c (HbA1c)Hepatic glucose-6-phosphate (G6P) levelsG6PC mRNA expression levelsHepatic triglyceride levels

Beyond the preview

Go deeper on Glucose-6-phosphatase catalytic subunit mRNA 3'-untranslated region (G6PC mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose-6-phosphatase catalytic subunit mRNA 3'-untranslated region (G6PC mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call